Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis

Gastroenterology
R LöfbergL Salde

Abstract

Systemic glucocorticosteroids (GCSs) have proven efficacy in active ulcerative colitis but cause undesired systemic side effects. Therefore, new GCSs with high topical activity and a high rate of metabolism may be of clinical value in this condition. The aim of this study was to explore the efficacy and safety of the topically acting GCS budesonide in an oral controlled-release formulation in extensive or left-sided, mild to moderately active ulcerative colitis. A 9-week, randomized, double-blind, controlled trial was performed, and treatments with 10 mg budesonide or 40 mg prednisolone daily, both gradually tapered, were compared. Endoscopic improvement and effect on endogenous plasma cortisol were assessed. Thirty-four patients were administered budesonide, and 38 patients were administered prednisolone. Mean endoscopic scores improved significantly in both groups but without difference between the groups. Five patients in the budesonide group and 7 patients in the prednisolone group deteriorated and were withdrawn from the study. Morning plasma cortisol levels were suppressed in the prednisolone group (entry, 449 nmol/L; 2 weeks, 116 nmol/L; 4 weeks, 195 nmol/L) but were unchanged in the budesonide group. The GCS budesonide ...Continue Reading

Citations

May 20, 1998·Postgraduate Medicine·P L MosesJ A Vecchio
Jan 20, 1999·Alimentary Pharmacology & Therapeutics·F M WardR V Heatley
Apr 10, 1999·Hospital Medicine·S Pathmakanthan, W A Stack
Sep 21, 2001·Alimentary Pharmacology & Therapeutics·K Ragunath, J G Williams
Jan 31, 2002·World Journal of Gastroenterology : WJG·David S Rampton, D Phil
Sep 9, 2004·Alimentary Pharmacology & Therapeutics·J Schölmerich
Jul 8, 2005·Journal of Clinical Gastroenterology·Seymour Katz
Jan 18, 2008·World Journal of Gastroenterology : WJG·Patricia L Kozuch, Stephen B Hanauer
Dec 2, 2009·Nature Reviews. Gastroenterology & Hepatology·Guillaume Pineton de ChambrunJean-Frédéric Colombel
Jan 8, 2014·Current Treatment Options in Gastroenterology·Byron P VaughnAdam S Cheifetz
Feb 18, 2014·Drugs·Stephan R VavrickaGerhard Rogler
Jun 3, 2014·Expert Review of Gastroenterology & Hepatology·Simone SaibeniFederica Fascì-Spurio
May 10, 2016·Expert Opinion on Pharmacotherapy·Maisa I Abdalla, Hans Herfarth
Jan 24, 2017·Alimentary Pharmacology & Therapeutics·L VuittonP Marteau
Apr 18, 1998·Medizinische Klinik·W FischbachH Zirngibl
Dec 6, 2000·Indian Journal of Pediatrics·P Vohra
Dec 24, 2005·Inflammatory Bowel Diseases·Ashish ChopraWilliam J Sandborn
Mar 22, 2002·Journal of Clinical Gastroenterology·Seymour Katz
Oct 18, 2005·Drugs·Steven MassonJohn C Mansfield
Jun 19, 2007·Orvosi hetilap·László Lakatos, Péter László Lakatos
Jan 14, 2010·The American Journal of Gastroenterology·Asher KornbluthUNKNOWN Practice Parameters Committee of the American College of Gastroenterology
Feb 12, 2009·The American Journal of Gastroenterology·Kalpesh ThakkarMark A Gilger
Feb 25, 2010·Journal of Pediatric Gastroenterology and Nutrition·Claudio RomanoWalter Fries
Mar 1, 2008·Journal of Crohn's & Colitis·S P L TravisUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Jun 10, 2011·Current Opinion in Gastroenterology·Wojciech BlonskiGary R Lichtenstein
Aug 2, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Ae Ryoung ParkHye Sun Gwak
Nov 6, 2015·Inflammatory Bowel Diseases·Nilesh ChandeBrian G Feagan
Apr 1, 2018·Journal of Gastroenterology and Hepatology·Stephan MiehlkeChris Probert
Oct 1, 1996·Scandinavian Journal of Gastroenterology·A Danielsson
Dec 21, 2002·The American Journal of Gastroenterology·S WinterkampM Raithel
Nov 17, 2006·American Journal of Hematology·Ismail SariMustafa Cetin
Apr 10, 2010·Expert Opinion on Drug Safety·Laura Noddin Rosenberg, Mark A Peppercorn
Nov 14, 2013·Expert Opinion on Pharmacotherapy·Klaudia Farkas, Tamás Molnár
Jul 1, 2010·Therapeutic Advances in Chronic Disease·Sarah O'Donnell, Colm A O'Morain
Mar 19, 2013·Therapeutic Advances in Gastroenterology·Cosimo Prantera, Stefano Marconi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.